Janssen George M C, Hensbergen Paul J, van Bussel Frans J, Balog Crina I A, Maassen J Antonie, Deelder André M, Raap Anton K
Department of Molecular Cell Biology, Leiden University Medical Centre, Post Zone S1-P, Einthovenweg 20, PO Box 9600, 2300RC Leiden, The Netherlands.
Hum Mol Genet. 2007 Oct 15;16(20):2472-81. doi: 10.1093/hmg/ddm203. Epub 2007 Jul 25.
Mutations in the mitochondrial tRNA(Leu(UUR)) gene are associated with a large variety of human diseases through a largely undisclosed mechanism. The A3243G tRNA(Leu(UUR)) mutation leads to reduction of mitochondrial DNA (mtDNA)-encoded proteins and oxidative phosphorylation activity even when the cells are competent in mitochondrial translation. These two aspects led to the suggestion that a dominant negative factor may underlie the diversity of disease expression. Here we test the hypothesis that A3243G tRNA(Leu(UUR)) generates such a dominant negative gain-of-function defect through misincorporation of amino acids at UUR codons of mtDNA-encoded proteins. Using an anti-complex IV immunocapture technique and mass spectrometry, we show that the mtDNA-encoded cytochrome c oxidase I (COX I) and COX II exist exclusively with the correct amino acid sequences in A3243G cells in a misassembled complex IV. A dominant negative component therefore cannot account for disease phenotype, leaving tissue-specific accumulation by mtDNA segregation as the most likely cause of variable mitochondrial disease expression.
线粒体tRNA(Leu(UUR))基因的突变通过一种很大程度上未被揭示的机制与多种人类疾病相关。即使细胞在线粒体翻译方面功能正常,A3243G tRNA(Leu(UUR))突变也会导致线粒体DNA (mtDNA)编码的蛋白质减少以及氧化磷酸化活性降低。这两个方面提示可能存在一个显性负性因子是疾病表现多样性的基础。在此,我们检验这样一个假说,即A3243G tRNA(Leu(UUR))通过在mtDNA编码蛋白质的UUR密码子处错误掺入氨基酸而产生这种显性负性功能获得性缺陷。使用抗细胞色素c氧化酶IV免疫捕获技术和质谱分析,我们发现mtDNA编码的细胞色素c氧化酶I (COX I)和COX II在A3243G细胞中仅以正确的氨基酸序列存在于组装错误的细胞色素c氧化酶IV复合物中。因此,显性负性成分不能解释疾病表型,mtDNA分离导致的组织特异性积累是线粒体疾病表现变异最可能的原因。